Ligand validation:5IWG

PG5: 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5IWG_PG5_A_405	8%	90%	0.264	0.735	0.5	0.12	-	-	0	0	100%	1
5IX0_PG5_B_409	20%	83%	0.186	0.788	0.5	0.29	-	-	0	0	100%	1
3D01_PG5_J_166	69%	76%	0.106	0.921	0.47	0.49	-	-	1	0	100%	1
8JU9_PG5_A_704	30%	56%	0.141	0.802	0.55	1.12	-	1	0	0	100%	1
4HT3_PG5_A_306	20%	45%	0.235	0.835	0.91	1.19	-	2	12	0	100%	1
8AQ3_PG5_A_606	12%	72%	0.187	0.744	0.58	0.51	-	-	2	0	83%	0.8333
3GVD_PG5_C_274	7%	49%	0.246	0.706	0.47	1.48	-	1	9	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.